1. Peters, DJ, Monnat, SM, Hochstetler, AL, Berg, MT. The opioid Hydra: understanding overdose mortality epidemics and syndemics across the rural-urban continuum. Rural Sociol. 2020;85:589-622. doi:10.1111/ruso.12307
Google Scholar | Crossref2. Sandbrink, F, Uppal, R. The time for opioid stewardship Is now. Jt Comm J Qual Patient Saf. 2019;45:1-2.
Google Scholar | Medline3. Wilson, N, Kariisa, M, Seth, P, Smith, H, Davis, NL. Drug and opioid-involved overdose deaths—United States, 2017-2018. MMWR Morb Mortal Wkly Rep. 2020;69:290-297.
Google Scholar | Crossref | Medline4. Olaisen, RH, Rossen, LM, Warner, M, Anderson, RN. Unintentional injury death rates in rural and urban areas: United States, 1999–2017. NCHS Data Brief 343. 2019. Accessed April 27, 2020. https://www.cdc.gov/nchs/products/databriefs/db343.htm
Google Scholar5. Dydyk, AM, Jain, NK, Gupta, M. Opioid Use Disorder. In: StatPearls. StatPearls Publishing; 2021. Accessed July 29, 2021. http://www.ncbi.nlm.nih.gov/books/NBK553166/
Google Scholar6. Oesterle, TS, Thusius, NJ, Rummans, TA, Gold, MS. Medication-assisted treatment for opioid-use disorder. Mayo Clin Proc. 2019;94:2072-2086.
Google Scholar | Crossref | Medline7. National Academies of Sciences, Engineering, and Medicine . Medications for Opioid Use Disorder Save Lives. The National Academies Press; 2019.
Google Scholar8. Winograd, RP, Presnall, N, Stringfellow, E, et al. The case for a medication first approach to the treatment of opioid use disorder. Am J Drug Alcohol Abuse. 2019;45:333-340.
Google Scholar | Crossref | Medline9. Agency for Healthcare Research and Quality . National Healthcare Quality and Disparities Report: Chartbook on Access to Health Care. Agency for Healthcare Research and Quality; 2016. Accessed April 7, 2020. https://www.ahrq.gov/research/findings/nhqrdr/chartbooks/access/elements.html
Google Scholar10. Institute of Medicine. Executive summary . Institute of Medicine. Executive summary. In: Rettig, RA, Yarmolinsky, A, eds. Federal Regulation of Methadone Treatment. National Academies Press; 1995. Accessed May 7, 2020. https://www.ncbi.nlm.nih.gov/books/NBK232111/
Google Scholar11. Substance Abuse and Mental Health Services Administration . Opioid Treatment Program Directory. Accessed May 7, 2020. https://dpt2.samhsa.gov/treatment/directory.aspx
Google Scholar12. Dick, AW, Pacula, RL, Gordon, AJ, et al. Growth in buprenorphine waivers for physicians increased potential access to opioid agonist treatment, 2002-11. Health Aff (Millwood). 2015;34:1028-1034.
Google Scholar | Crossref | Medline13. Haffajee, RL, Bohnert, ASB, Lagisetty, PA. Policy pathways to address provider workforce barriers to buprenorphine treatment. Am J Prev Med. 2018;54:S230-S242.
Google Scholar | Crossref | Medline14. Joudrey, PJ, Edelman, EJ, Wang, EA. Drive times to opioid treatment programs in urban and rural counties in 5 US States. JAMA. 2019;322:1310-1312.
Google Scholar | Crossref | Medline15. Clark, RE, Samnaliev, M, Baxter, JD, Leung, GY. The evidence doesn’t justify steps by state medicaid programs to restrict opioid addiction treatment with buprenorphine. Health Aff (Millwood). 2011;30:1425-1433.
Google Scholar | Crossref | Medline16. Lee, JD, Nunes, EV, Novo, P, et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. Lancet. 2018;391:309-318.
Google Scholar | Crossref | Medline17. Korthuis, PT, McCarty, D, Weimer, M, et al. Primary care-based models for the treatment of opioid use disorder: a scoping review. Ann Intern Med. 2017;166:268-278.
Google Scholar | Crossref | Medline18. Jones, CM, Campopiano, M, Baldwin, G, McCance-Katz, E. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health. 2015;105:e55-e63.
Google Scholar | Crossref | Medline | ISI19. Knudsen, HK, Havens, JR, Lofwall, MR, Studts, JL, Walsh, SL. Buprenorphine physician supply: relationship with state-level prescription opioid mortality. Drug Alcohol Depend. 2017;173:S55-S64.
Google Scholar | Crossref | Medline20. Knudsen, HK. The supply of physicians waivered to prescribe buprenorphine for opioid use disorders in the United States: a state-level analysis. J Stud Alcohol Drugs. 2015;76:644-654.
Google Scholar | Crossref | Medline21. Langabeer, JR, Gourishankar, A, Chambers, KA, Giri, S, Madu, R, Champagne-Langabeer, T. Disparities between US opioid overdose deaths and treatment capacity: a geospatial and descriptive analysis. J Addict Med. 2019;13:476-482.
Google Scholar | Crossref | Medline22. Andrilla, CHA, Patterson, DG, Moore, TE, Coulthard, C, Larson, EH. Projected contributions of nurse practitioners and physicians assistant to buprenorphine treatment services for opioid use disorder in rural areas. Med Care Res Rev. 2020;77:208-216. doi:10.1177/1077558718793070
Google Scholar | SAGE Journals | ISI23. Andrilla, CHA, Coulthard, C, Patterson, DG. Prescribing practices of rural physicians waivered to prescribe buprenorphine. Am J Prev Med. 2018;54:S208-S214.
Google Scholar | Crossref24. Davis, CS. The SUPPORT for Patients and Communities Act—what will it mean for the opioid-overdose crisis? N Engl J Med. 2019;380:3-5.
Google Scholar | Crossref | Medline25. Barnes, H, Richards, MR, McHugh, MD, Martsolf, G. Rural and nonrural primary care physician practices increasingly rely on nurse practitioners. Health Aff (Millwood). 2018;37:908-914.
Google Scholar | Crossref | Medline26. Petterson, S, McNellis, R, Klink, K, Meyers, D, Bazemore, A. The State of Primary Care in the United States: A Chartbook of Facts and Statistics. Robert Graham Center; 2018. Accessed June 23, 2020. https://www.graham-center.org/content/dam/rgc/documents/publications-reports/reports/PrimaryCareChartbook.pdf
Google Scholar27. Barnett, ML, Lee, D, Frank, RG. In rural areas, buprenorphine waiver adoption since 2017 driven by nurse practitioners and physician assistants. Health Aff (Millwood). 2019;38:2048-2056.
Google Scholar | Crossref | Medline28. Bailey, MJ, Goodman-Bacon, A. The war on poverty’s experiment in public medicine: community health centers and the mortality of older Americans. Am Econ Rev. 2015;105:1067-1104.
Google Scholar | Crossref | Medline29. Heisler, EJ. Federal health centers: an overview. Congressional Research Service; 2017. Accessed June 7, 2021. https://fas.org/sgp/crs/misc/R43937.pdf
Google Scholar30. Health Resources and Services Administration . About the Health Center Program. Bureau of Primary Health Care; 2016. Accessed January 15, 2021. https://bphc.hrsa.gov/about/index.html
Google Scholar31. Health Resources and Services Administration . Health Center Program: Impact and Growth. Bureau of Primary Health Care; 2018. Accessed December 14, 2020. https://bphc.hrsa.gov/about/healthcenterprogram/index.html
Google Scholar32. U. S. Census Bureau . U.S. Census Bureau QuickFacts: United States. 2019. Accessed January 15, 2021. https://www.census.gov/quickfacts/fact/table/US/PST045219
Google Scholar33. Health Resources and Services Administration . National health center data. 2019. Accessed December 18, 2020. https://data.hrsa.gov/tools/data-reporting/program-data/national
Google Scholar34. Haddad, MS, Zelenev, A, Altice, FL. Integrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes. Drug Alcohol Depend. 2013;131:127-135.
Google Scholar | Crossref | Medline35. Haddad, MS, Zelenev, A, Altice, FL. Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers. J Urban Health Bull N Y Acad Med. 2015;92:193-213.
Google Scholar | Crossref | Medline36. Volkow, ND . Access to Addiction Services Differs by Race and Gender. Nora’s Blog, National Institute of Drug Abuse; 2019. Accessed December 18, 2020. https://www.drugabuse.gov/about-nida/noras-blog/2019/07/access-to-addiction-services-differs-by-race-gender
Google Scholar37. Lagisetty, PA, Ross, R, Bohnert, A, Clay, M, Maust, DT. Buprenorphine treatment divide by race/ethnicity and payment. JAMA Psychiatr. 2019;76:979-981.
Google Scholar | Crossref | Medline38. Saloner, B, Cook, BL. Blacks and hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors. Health Aff. 2013;32:135-145.
Google Scholar | Crossref | Medline | ISI39. Arndt, S, Clayton, R, Schultz, SK. Trends in substance abuse treatment 1998-2008: increasing older adult first-time admissions for illicit drugs. Am J Geriatr Psychiatr. 2011;19:704-711.
Google Scholar | Crossref | Medline40. Hall, SA, Kaufman, JS, Ricketts, TC. Defining urban and rural areas in U.S. epidemiologic studies. J Urban Health. 2006;83:162-175.
Google Scholar | Crossref | Medline | ISI41. Morrill, R, Cromartie, J, Hart, G. Metropolitan, urban, and rural commuting areas: toward a better depiction of the United States settlement system. Urban Geogr. 1999;20:727-748.
Google Scholar | Crossref | ISI42. Joudrey, PJ, Chadi, N, Roy, P, et al. Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: a cross-sectional study. Drug Alcohol Depend. 2020;211:107968.
Google Scholar | Crossref | Medline43. Scott, CK, Grella, CE, Dennis, ML, Nicholson, L. Linking individuals with substance use disorders (SUDs) in primary care to SUD treatment: the recovery management checkups-primary care (RMC-PC) pilot study. J Behav Health Serv Res. 2018;45:160-173.
Google Scholar | Medline44. Miller, BF, Petterson, S, Brown Levey, SM, Payne-Murphy, JC, Moore, M, Bazemore, A. Primary care, behavioral health, provider colocation, and rurality. J Am Board Fam Med. 2014;27:367-374.
Google Scholar | Crossref | Medline | ISI45. Bosanac, EM, Parkinson, RC, Hall, DS. Geographic access to hospital care: a 30-minute travel time standard. Med Care. 1976;14:616-624.
Google Scholar | Crossref | Medline | ISI46. Delamater, PL, Messina, JP, Shortridge, AM, Grady, SC. Measuring geographic access to health care: raster and network-based methods. Int J Health Geogr. 2012;11:15.
Google Scholar | Crossref | Medline47. Yen, W . How Long and How Far Do Adults Travel and Will Adults Travel for Primary Care? The Health Care Research Group, Washington State Office of Financial Management; 2013. Accessed May 26, 2021. https://ofm.wa.gov/sites/default/files/public/legacy/researchbriefs/2013/brief070.pdf
Google Scholar48. Zur, J, Tolbert, J, Sharac, J, Markus, A. The Role of Community Health Centers in Addressing the Opioid Epidemic. Kaiser Family Foundation; 2018. Accessed December 18, 2020. https://www.kff.org/medicaid/issue-brief/the-role-of-community-health-centers-in-addressing-the-opioid-epidemic/
Google Scholar49. National Association of Community Health Centers . Removing Barriers to Care: Community Health Centers in Rural Areas. 2013. Accessed May 26, 2021. http://www.nachc.org/wp-content/uploads/2015/06/Rural_FS_1013.pdf
Google Scholar50. Lapham, G, Boudreau, DM, Johnson, EA, et al. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020;207:107732.
Google Scholar | Crossref | Medline51. Cantone, RE, Garvey, B, O’Neill, A, et al. Predictors of medication-assisted treatment initiation for opioid use disorder in an interdisciplinary primary care model. J Am Board Fam Med. 2019;32:724-731.
Google Scholar | Crossref | Medline52. Kilaru, AS, Xiong, A, Lowenstein, M, et al. Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Netw Open. 2020;3:e205852.
Google Scholar | Crossref53. U. S. Census Bureau . Selected Characteristics of Health Insurance Coverage in The United States. American Community Survey; 2019. Accessed January 15, 2021. https://data.census.gov/cedsci/table?q=ACSST1Y2019.S2701&g=0400000US04&tid=ACSST1Y2019.S2701&hidePreview=true
Google Scholar54. U. S. Census Bureau . Public Health Insurance Coverage by Type and Selected Characteristics. American Community Survey; 2019. Accessed January 15, 2021. https://data.census.gov/cedsci/table?q=ACSST1Y2019.S2704&g=0400000US04&tid=ACSST1Y2019.S2704&hidePreview=true
Google Scholar55. Rosenblatt, RA, Andrilla, CH, Catlin, M, Larson, EH. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med. 2015;13:23-26.